Cell Cycle Dysregulation in Mantle Cell Lymphoma-Reference-Cited by-同舟云学术

Cell Cycle Dysregulation in Mantle Cell Lymphoma

Published:2020-10 Issue:5 Volume:34 Page:809-823
ISSN:0889-8588
Container-title:Hematology/Oncology Clinics of North America
language:en
Short-container-title:Hematology/Oncology Clinics of North America

Author:

Wang Kevin,Huang Xiangao,Di Liberto Maurizio,Chen-Kiang Selina

Funder

V Foundation

NIH

HCA Foundation

Publisher

Elsevier BV

Subject

Oncology,Hematology

Reference61 articles.

1. Chromosome t(11;14)(q13;q32) breakpoints in centrocytic lymphoma are highly localized at the bcl-1 major translocation cluster;Williams;Leukemia,1993

2. PRAD-1/cyclin D1 gene overexpression in chronic lymphoproliferative disorders: a highly specific marker of mantle cell lymphoma;Bosch;Blood,1994

3. Cyclin D1 messenger RNA overexpression as a marker for mantle cell lymphoma;de Boer;Oncogene,1995

4. bcl-1 rearrangement and cyclin D1 protein expression in mantle cell lymphoma;Ott;J Pathol,1996

5. PRAD1, a candidate BCL1 oncogene: mapping and expression in centrocytic lymphoma;Rosenberg;Proc Natl Acad Sci U S A,1991

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prostate cancer and the cell cycle: Focusing on the role of microRNAs;Gene;2024-11

2. Exploring the anti-atherosclerosis mechanism of ginsenoside Rb1 by integrating network pharmacology and experimental verification;Aging;2024-03-27

3. Cyclin dependent kinase 4/6 inhibitor palbociclib synergizes with BCL2 inhibitor venetoclax in experimental models of mantle cell lymphoma without RB1 deletion;Experimental Hematology & Oncology;2024-03-25

4. B‐Cell Chronic Lymphocytic Leukemia and B‐Cell Lymphomas: The Key Role of Micro and Long Noncoding RNAs;Journal of Clinical Pharmacy and Therapeutics;2024-01

5. Resistance to PRMT5-targeted therapy in mantle cell lymphoma;Blood Advances;2023-12-29